View Older Stories View More Recent Stories
-
AVEO Oncology Reports Second Quarter 2020 Financial Results and Provides Business Update
-
BioSpecifics Reports Second Quarter 2020 Financial and Operating Results
-
Nuvo Pharmaceuticals® Announces Second Quarter 2020 Results
-
Blade Therapeutics Appoints Accomplished Biopharmaceutical Executive, Mark Timney, as Chairman of the Board
-
Quartet Health Partners With SilverCloud Health to Expand Access to Mental Health Care Options Nationwide
-
Melinta Therapeutics Announces Appointment of Christine Ann Miller as President and Chief Executive Officer
-
Melinta Therapeutics Announces Appointment of Christine Ann Miller as President and Chief Executive Officer
-
Form SC 13D Deerfield Healthcare Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Sema4 Closes $121 Million Series C Led by BlackRock Funds
-
Lumos Pharma to Report Second Quarter 2020 Financial Results and Host a Conference Call on August 13, 2020
-
Lumos Pharma to Report Second Quarter 2020 Financial Results and Host a Conference Call on August 13, 2020
-
Lumos Pharma, Inc. (LUMO) Sells Priority Review Voucher (PRV) to Merck at $100M Valuation
-
Lumos Pharma Announces Sale of Priority Review Voucher
-
Lumos Pharma Announces Sale of Priority Review Voucher
-
Deerfield Healthcare Technology Acquisitions Corp. Announces Closing of $143.75 Million Initial Public Offering
-
UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S. healthcare investment firm
-
BioSpecifics Appoints Alex Monteith as Chief Business Officer
-
IPO of SPAC Deerfield Healthcare Technology Acquisitions (DFHT) (DFHTU) Opens Modestly Higher
-
Deerfield Healthcare Technology Acquisitions Corp. (DFHT) Prices 12.5M Unit IPO at $10/Unit
-
Deerfield Healthcare Technology Acquisitions Corp. Announces Pricing of $125 Million Initial Public Offering
-
Centene and Quartet Health expand partnership nationwide to help ensure members have access to critical behavioral health care during COVID-19 pandemic and beyond
-
Liquid Wire Closes $10 Million Series A to Bring Stretchable Electronics Technologies to the Medical Wearables Industry
-
AdaptHealth Closes Previously Announced Acquisitions of Solara Medical Supplies and ActivStyle
-
Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics
-
Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics
-
Somatus Raises $64 Million in Series C Financing to Transform Kidney Care
-
Nkarta Therapeutics Presents Preclinical Findings Supporting Gene Editing of Natural Killer Cells and the Combination of Engineered NK plus T Cells at the American Association for Cancer Research (AAC
-
Nkarta Therapeutics Presents Preclinical Findings Supporting Gene Editing of Natural Killer Cells and the Combination of Engineered NK plus T Cells at the American Association for Cancer Research (AAC
-
InVitae (NVTA) to Combine with ArcherDX
-
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
-
Dracen announces two DRP-104 presentations at AACR
-
KemPharm Issues Letter to Shareholders
-
Form 4 Generation Bio Co. For: Jun 16 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Fast-Growing Health Care Service to Provide At-Home COVID-19 Testing and Medical Care for D.C. Residents
-
Melinta Therapeutics (MLNT) to Acquire Tetraphase Pharmaceuticals for $39M, plus $16M in CVRs
-
Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase Pharmaceuticals
-
Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase Pharmaceuticals
-
CureDuchenne Ventures Announces The "CureDuchenne Ventures 2020 Pitch Contest," To Award Two $25,000 Prizes For Novel Ideas In Duchenne Muscular Dystrophy Therapy Development
-
Meditrina, Inc. completes $10M equity financing led by Deerfield
-
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
-
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
-
Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
-
Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
-
Lumos Pharma to Participate in the Jefferies 2020 Healthcare Conference
-
Lumos Pharma to Participate in the Jefferies 2020 Healthcare Conference
-
Deerfield Commits Up to $130 Million to Commercialize Drug Discovery at University of Michigan
-
Conventus Orthopaedics, Inc. Announces Acquisition of Flower Orthopedics
-
Lumos Pharma to Report First Quarter 2020 Financial Results and Host a Conference Call on May 28, 2020
-
Lumos Pharma to Report First Quarter 2020 Financial Results and Host a Conference Call on May 28, 2020
-
AdaptHealth Expands Into Diabetes Segment With Accretive Acquisition of Leading Distributor Solara Medical Supplies

